Potentially, the frequent loss of PAX2 in SCOUTs, STICs and high-grade serous ovarian cancers is essential to allow for the stem cell-like plasticity required for tumor progression. The gene discussed is PAX2; the disease is ovarian serous adenocarcinoma.